Inhibrx Biosciences, Inc. INBX
NASDAQ · United States · Health Technology
$97.93-2.15 (-2.15%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -2.34 | -2.28 | -2.6% | $0 | — | -10.2%$98.36→$88.37 |
| Q1 2026 | 2026-05-14 | -2.15 | -1.20 | -79.2% | — | — | -7.9%$117.95→$108.64 |
| Q4 2025 | 2026-03-19 | -2.11 | -2.08 | -1.4% | — | — | -11.3%$68.69→$60.92 |
| Q3 2025 | 2025-11-14 | -2.28 | -1.72 | -32.6% | — | — | +3.7%$74.62→$77.35 |
| Q2 2025 | 2025-08-13 | -1.85 | -2.76 | +33.0% | — | — | — |
| Q1 2025 | 2025-05-14 | -2.80 | -3.12 | +10.3% | — | — | — |
| Q4 2024 | 2025-03-17 | -4.47 | -2.88 | -55.2% | — | — | — |
| Q3 2024 | 2024-11-14 | -2.84 | -3.70 | +23.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.